$TDOC
Teladoc Health, Inc.

2024 Q3 Form 10-Q Financial Statement

#000147744924000174 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $640.5M $642.4M
YoY Change -2.99% -1.53%
Cost Of Revenue $179.7M $188.1M
YoY Change -3.36% -1.3%
Gross Profit $460.8M $454.4M
YoY Change -2.85% -1.62%
Gross Profit Margin 71.94% 70.73%
Selling, General & Admin $161.7M $160.0M
YoY Change -3.76% -10.8%
% of Gross Profit 35.1% 35.21%
Research & Development $72.38M $76.75M
YoY Change -14.13% -12.09%
% of Gross Profit 15.71% 16.89%
Depreciation & Amortization $89.57M $96.57M
YoY Change -5.02% 27.96%
% of Gross Profit 19.44% 21.25%
Operating Expenses $234.1M $236.7M
YoY Change -7.22% -11.23%
Operating Profit -$44.40M -$841.1M
YoY Change -31.4% 1074.05%
Interest Expense $5.660M $5.648M
YoY Change 0.25% -3.2%
% of Operating Profit
Other Income/Expense, Net $2.239M -$563.0K
YoY Change -224.94% 171.98%
Pretax Income -$32.50M -$833.8M
YoY Change -45.44% 1160.85%
Income Tax $780.0K $3.884M
% Of Pretax Income
Net Earnings -$33.28M -$837.7M
YoY Change -41.7% 1185.22%
Net Earnings / Revenue -5.2% -130.39%
Basic Earnings Per Share -$0.19 -$4.92
Diluted Earnings Per Share -$0.19 -$4.92
COMMON SHARES
Basic Shares Outstanding 171.2M shares 169.6M shares
Diluted Shares Outstanding 171.5M shares 170.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.244B $1.162B
YoY Change 20.65% 21.25%
Cash & Equivalents $1.244B $1.162B
Short-Term Investments
Other Short-Term Assets $983.0K $5.837M
YoY Change -88.17% -30.25%
Inventory $36.99M $34.90M
Prepaid Expenses $68.47M $78.25M
Receivables $212.0M $218.4M
Other Receivables $11.50M $11.54M
Total Short-Term Assets $1.609B $1.547B
YoY Change 15.97% 17.09%
LONG-TERM ASSETS
Property, Plant & Equipment $28.03M $29.33M
YoY Change -14.77% -3.49%
Goodwill $283.2M $283.2M
YoY Change -73.61% -73.61%
Intangibles $1.497B $1.547B
YoY Change -13.4% -13.26%
Long-Term Investments
YoY Change
Other Assets $77.91M $81.43M
YoY Change 4.65% 11.65%
Total Long-Term Assets $1.920B $1.977B
YoY Change -34.72% -34.0%
TOTAL ASSETS
Total Short-Term Assets $1.609B $1.547B
Total Long-Term Assets $1.920B $1.977B
Total Assets $3.529B $3.524B
YoY Change -18.47% -18.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.80M $56.11M
YoY Change 45.4% 249.14%
Accrued Expenses $254.5M $228.5M
YoY Change 13.13% 9.78%
Deferred Revenue $88.33M $95.43M
YoY Change -10.96% -11.13%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $550.7M $550.7M
YoY Change
Total Short-Term Liabilities $931.4M $930.7M
YoY Change 131.32% 142.76%
LONG-TERM LIABILITIES
Long-Term Debt $990.6M $989.7M
YoY Change -35.59% -35.61%
Other Long-Term Liabilities $736.0K $1.007M
YoY Change -56.53% -42.13%
Total Long-Term Liabilities $736.0K $1.007M
YoY Change -56.53% -42.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $931.4M $930.7M
Total Long-Term Liabilities $736.0K $1.007M
Total Liabilities $2.021B $2.022B
YoY Change 399.81% 424.9%
SHAREHOLDERS EQUITY
Retained Earnings -$16.18B -$16.15B
YoY Change 6.46% 6.64%
Common Stock $17.73B $17.69B
YoY Change 1.09% 1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.508B $1.502B
YoY Change
Total Liabilities & Shareholders Equity $3.529B $3.524B
YoY Change -18.47% -18.37%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$33.28M -$837.7M
YoY Change -41.7% 1185.22%
Depreciation, Depletion And Amortization $89.57M $96.57M
YoY Change -5.02% 27.96%
Cash From Operating Activities $110.2M $88.68M
YoY Change 4.33% -12.35%
INVESTING ACTIVITIES
Capital Expenditures $31.15M $27.75M
YoY Change -17.16% -24.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$31.15M -$27.75M
YoY Change -17.16% -24.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 698.0K 3.805M
YoY Change -86.04% -9.58%
NET CHANGE
Cash From Operating Activities 110.2M 88.68M
Cash From Investing Activities -31.15M -27.75M
Cash From Financing Activities 698.0K 3.805M
Net Change In Cash 79.73M 64.74M
YoY Change 9.21% -5.93%
FREE CASH FLOW
Cash From Operating Activities $110.2M $88.68M
Capital Expenditures $31.15M $27.75M
Free Cash Flow $79.03M $60.94M
YoY Change 16.22% -5.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
642444000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72511000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82194000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2677000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
677000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2798000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
5435000 usd
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
83000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5556000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7561000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
39899000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
39705000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1191000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
808000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1123675000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1162383000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
958695000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4613000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
785000 usd
us-gaap Interest Paid
InterestPaid
8662000 usd
us-gaap Interest Paid
InterestPaid
8676000 usd
CY2024Q2 tdoc Inventory Raw Materials And Purchased Parts Gross
InventoryRawMaterialsAndPurchasedPartsGross
9387000 usd
CY2023Q4 tdoc Inventory Raw Materials And Purchased Parts Gross
InventoryRawMaterialsAndPurchasedPartsGross
9338000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
723000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
299000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
24786000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19876000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.teladoc.com/20240630#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.teladoc.com/20240630#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.teladoc.com/20240630#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.44
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170229583 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170229583 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168980165 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168980165 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163550481 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163550481 shares
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3153000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45497000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-337000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-837671000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1502086000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2326073000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2677000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3153000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91719000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1976000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919560000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1502086000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2291226000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
381000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5790000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60707000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2217000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-65177000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2295144000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2307745000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
677000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5790000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111341000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3996000 usd
us-gaap Net Income Loss
NetIncomeLoss
-134405000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2295144000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919560000 usd
us-gaap Net Income Loss
NetIncomeLoss
-134405000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
790000000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189919000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
139371000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
4537000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
5877000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4902000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5778000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3048000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
84432000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
101763000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1368000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3557000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2695000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7587000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2971000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7032000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13017000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16625000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6032000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20613000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-676000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
17463000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12614000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-31788000 usd
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
154000 usd
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
20742000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-45802000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15532000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1638000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7546000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5424000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4946000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-60000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
111000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
97603000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
114338000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3061000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4267000 usd
us-gaap Payments For Software
PaymentsForSoftware
60199000 usd
us-gaap Payments For Software
PaymentsForSoftware
77927000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63260000 usd
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
1450000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
918182000 usd
tdoc Property And Equipment Net And Intangibles Net Accruals Incurred But Not Yet Paid
PropertyAndEquipmentNetAndIntangiblesNetAccrualsIncurredButNotYetPaid
3099000 usd
tdoc Property And Equipment Net And Intangibles Net Accruals Incurred But Not Yet Paid
PropertyAndEquipmentNetAndIntangiblesNetAccrualsIncurredButNotYetPaid
8580000 usd
us-gaap Nature Of Operations
NatureOfOperations
Organization and Description of Business<div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health,” or the “Company,” and is the global leader in whole person virtual care, forging a new healthcare experience with better convenience, outcomes, and value. The Company’s mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. The Company’s principal executive office is located in Purchase, New York.</span></div>
tdoc Number Of Professional Associations Consolidated As Variable Interest Entities
NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities
2 professionalassociation
tdoc Number Of Professional Corporations Consolidated As Variable Interest Entities
NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities
10 professionalcorporation
us-gaap Use Of Estimates
UseOfEstimates
<div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business and economic factors, and various other assumptions that the Company believes are necessary to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s condensed consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. The Company believes that estimates used in the preparation of these condensed consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in the Condensed Consolidated Statements of Operations; if material, the effects of changes in estimates are disclosed in the Notes to Unaudited Condensed Consolidated Financial Statements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates and assumptions by management affect areas including the value and useful life of long-lived assets (including intangible assets), the capitalization and amortization of software development costs, deferred device and contract costs, allowances for sales and for doubtful accounts, and the accounting for business combinations. Other significant areas include revenue recognition (including performance guarantees), the accounting for income taxes, contingencies, litigation and related legal accruals, the accounting for stock-based compensation awards, and other items as described in Note 2. “Basis of Presentation and Principles of Consolidation" in the Summary of Significant Accounting policies in the 2023 Form 10-K and as may be updated in this Quarterly Report in Note 2. “Basis of Presentation and Principles of Consolidation."</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></div>
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
642444000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
652406000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1288575000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1281650000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
652406000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1288575000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1281650000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
109282000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
113786000 usd
tdoc Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
66593000 usd
tdoc Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
84591000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
68698000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
76752000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
107177000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
121625000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
78500000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21900000 usd
CY2024Q2 tdoc Deferred Device Cost And Other Current
DeferredDeviceCostAndOtherCurrent
35330000 usd
CY2023Q4 tdoc Deferred Device Cost And Other Current
DeferredDeviceCostAndOtherCurrent
32703000 usd
CY2024Q2 tdoc Deferred Device Cost And Other Noncurrent
DeferredDeviceCostAndOtherNoncurrent
17448000 usd
CY2023Q4 tdoc Deferred Device Cost And Other Noncurrent
DeferredDeviceCostAndOtherNoncurrent
17573000 usd
CY2024Q2 tdoc Deferred Device Cost And Other
DeferredDeviceCostAndOther
52778000 usd
CY2023Q4 tdoc Deferred Device Cost And Other
DeferredDeviceCostAndOther
50276000 usd
tdoc Deferred Device Cost And Other Additions
DeferredDeviceCostAndOtherAdditions
19188000 usd
tdoc Deferred Device Cost And Other Cost Of Revenue Recognized
DeferredDeviceCostAndOtherCostOfRevenueRecognized
16686000 usd
CY2024Q2 tdoc Deferred Device Cost And Other
DeferredDeviceCostAndOther
52778000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
34896000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
29513000 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78251000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
65651000 usd
CY2024Q2 tdoc Deferred Device Cost And Other Current
DeferredDeviceCostAndOtherCurrent
35330000 usd
CY2023Q4 tdoc Deferred Device Cost And Other Current
DeferredDeviceCostAndOtherCurrent
32703000 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
11538000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
12640000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5837000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7443000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
130956000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
118437000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1073190000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
283190000 usd
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
790000000.0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
790000000.0 usd
CY2024Q2 tdoc Goodwill Impairment Loss Per Share
GoodwillImpairmentLossPerShare
4.64
tdoc Goodwill Impairment Loss Per Share
GoodwillImpairmentLossPerShare
4.68
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
14200000000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
12300000000 usd
CY2022Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2641512000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1094014000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1547498000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2584733000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
906952000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1677781000 usd
CY2024Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
30760000 usd
CY2023Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
19749000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
61636000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
36350000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94862000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189919000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
139371000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
174604000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
293052000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
239825000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
166337000 usd
CY2024Q2 tdoc Finite Lived Intangible Asset Expected Amortization Year Four And Thereafter
FiniteLivedIntangibleAssetExpectedAmortizationYearFourAndThereafter
673680000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1547498000 usd
CY2024Q2 tdoc Cloud Computing Costs Net
CloudComputingCostsNet
43100000 usd
CY2023Q4 tdoc Cloud Computing Costs Net
CloudComputingCostsNet
41100000 usd
CY2024Q2 tdoc Cloud Computing Expense
CloudComputingExpense
1200000 usd
CY2023Q2 tdoc Cloud Computing Expense
CloudComputingExpense
1000000.0 usd
tdoc Cloud Computing Expense
CloudComputingExpense
2400000 usd
tdoc Cloud Computing Expense
CloudComputingExpense
1800000 usd
CY2024Q2 tdoc Revenue From Contract With Customer Performance Guarantees Current
RevenueFromContractWithCustomerPerformanceGuaranteesCurrent
34283000 usd
CY2023Q4 tdoc Revenue From Contract With Customer Performance Guarantees Current
RevenueFromContractWithCustomerPerformanceGuaranteesCurrent
36934000 usd
CY2024Q2 tdoc Accrued Marketing And Advertising Current
AccruedMarketingAndAdvertisingCurrent
31155000 usd
CY2023Q4 tdoc Accrued Marketing And Advertising Current
AccruedMarketingAndAdvertisingCurrent
34427000 usd
CY2024Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
16459000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
12933000 usd
CY2024Q2 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
15390000 usd
CY2023Q4 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
16416000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10718000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10752000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
9750000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
9910000 usd
CY2024Q2 tdoc Accrued Information Technology Expense Current
AccruedInformationTechnologyExpenseCurrent
8007000 usd
CY2023Q4 tdoc Accrued Information Technology Expense Current
AccruedInformationTechnologyExpenseCurrent
7605000 usd
CY2024Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
7453000 usd
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
5777000 usd
CY2024Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3243000 usd
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3800000 usd
CY2024Q2 tdoc Other Current Liabilities Staff Augmentation
OtherCurrentLiabilitiesStaffAugmentation
2662000 usd
CY2023Q4 tdoc Other Current Liabilities Staff Augmentation
OtherCurrentLiabilitiesStaffAugmentation
4287000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1482000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1481000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
756000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
621000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32446000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
33691000 usd
CY2024Q2 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
173804000 usd
CY2023Q4 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
178634000 usd
CY2024Q2 tdoc Debt Instrument Number Of Series Of Convertible Senior Debt Outstanding
DebtInstrumentNumberOfSeriesOfConvertibleSeniorDebtOutstanding
3 debtseries
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
1540408000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
1538688000 usd
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
550722000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
989686000 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1538688000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
1540408000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
1538688000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6800000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12359000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11173000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8078000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5909000 usd
CY2024Q2 tdoc Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
12961000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
57280000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8846000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
48434000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10718000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37716000 usd
CY2024Q2 us-gaap Restructuring Costs
RestructuringCosts
1500000 usd
us-gaap Restructuring Costs
RestructuringCosts
11200000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
7500000 usd
us-gaap Restructuring Costs
RestructuringCosts
15600000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10914892 shares
CY2024Q2 tdoc Share Based Compensation Arrangement By Share Based Payment Award Aggregate Grant Date Target Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateGrantDateTargetValue
15000000.0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4182187 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.37
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M3D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13732000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
32477 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.66
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
247013 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
674000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
420272 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
38.85
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3547379 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M7D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2237000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3547379 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
27.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y3M7D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2237000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2920285 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.95
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M6D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2237000 usd
CY2024Q2 tdoc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue
0.0 usd
CY2023Q2 tdoc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue
600000 usd
tdoc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue
400000 usd
tdoc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue
800000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42107000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55725000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
84432000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
101763000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3390000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4982000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
7287000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
9578000 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
45497000 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
60707000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
91719000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
111341000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6600000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000.0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
642444000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
652406000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1288575000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1281650000 usd
tdoc Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
152621000 usd
tdoc Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
124920000 usd
CY2024Q2 tdoc Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
89481000 usd
CY2023Q2 tdoc Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
72155000 usd
tdoc Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
152621000 usd
tdoc Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
124920000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42107000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55725000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
84432000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
101763000 usd
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
790000000 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
790000000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
457000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5080000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
830000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11024000 usd
CY2024Q2 us-gaap Restructuring Costs
RestructuringCosts
1500000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
7530000 usd
us-gaap Restructuring Costs
RestructuringCosts
11173000 usd
us-gaap Restructuring Costs
RestructuringCosts
15632000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94862000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72511000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189919000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
139371000 usd
CY2024Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1703000 usd
CY2023Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2954000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
4537000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
5877000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
13572000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
11558000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
27514000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
20469000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
5648000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
5835000 usd
us-gaap Interest Expense
InterestExpense
11297000 usd
us-gaap Interest Expense
InterestExpense
11098000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-563000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-207000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-933000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4700000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-833787000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66129000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-912986000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-134676000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3884000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-952000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6574000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-271000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-837671000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-65177000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919560000 usd
us-gaap Net Income Loss
NetIncomeLoss
-134405000 usd
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
29330000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
32032000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
tdoc-20240630_cal.xml Edgar Link unprocessable
tdoc-20240630_lab.xml Edgar Link unprocessable
0001477449-24-000174-index-headers.html Edgar Link pending
0001477449-24-000174-index.html Edgar Link pending
0001477449-24-000174.txt Edgar Link pending
0001477449-24-000174-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tdoc-20240630.htm Edgar Link pending
tdoc-20240630.xsd Edgar Link pending
tdoc-20240630xexx103.htm Edgar Link pending
tdoc-20240630xexx104.htm Edgar Link pending
tdoc-20240630xexx311.htm Edgar Link pending
tdoc-20240630xexx312.htm Edgar Link pending
tdoc-20240630xexx321.htm Edgar Link pending
tdoc-20240630xexx322.htm Edgar Link pending
tdoc-20240630_pre.xml Edgar Link unprocessable
tdoc-20240630_htm.xml Edgar Link completed
tdoc-20240630_def.xml Edgar Link unprocessable